Literature DB >> 19887486

Production of interferon-{gamma}-inducible protein-10 and its role as an autocrine invasion factor in nasal natural killer/T-cell lymphoma cells.

Shigetaka Moriai1, Miki Takahara, Takeshi Ogino, Toshihiro Nagato, Kan Kishibe, Hideyuki Ishii, Akihiro Katayama, Norio Shimizu, Yasuaki Harabuchi.   

Abstract

PURPOSE: Nasal natural killer (NK)/T-cell lymphoma is associated with Epstein-Barr virus and has poor prognosis because of local invasion and/or multiple dissemination. Recently, the role of chemokines/chemokine receptors in tumor proliferation and invasion has been shown. In this study, we examined whether the specific chemokines were related to the tumor behaviors in nasal NK/T-cell lymphoma. EXPERIMENTAL
DESIGN: A chemokine protein array was used to examine specific chemokines produced by SNK-6 and SNT-8 (Epstein-Barr virus-positive nasal NK/T-cell lymphoma lines). The expression of interferon gamma-inducible protein 10 (IP-10) and the IP-10 receptor CXCR3 was investigated by ELISA and flow cytometry. Cell growth and invasion were assessed by the MTT and Matrigel invasion assays, respectively. Immunohistologic staining and ELISA were used to examine IP-10 expression in biopsies and sera from patients, respectively.
RESULTS: IP-10 was specifically produced by SNK-6 and SNT-8. Moreover, CXCR3 was expressed on the NK cell lines. Functionally, IP-10 did not affect cell proliferation but enhanced cell invasion. In biopsy samples, IP-10 and CXCR3 expressions were detected in the lymphoma cells. Serum IP-10 levels in the patients were much higher than those of healthy controls and the levels were decreased during the complete remission phase after treatments.
CONCLUSIONS: These results suggest that IP-10 may play an important role in cell invasion in nasal NK/T-cell lymphoma through an autocrine mechanism.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19887486     DOI: 10.1158/1078-0432.CCR-09-1052

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  17 in total

Review 1.  Emerging insights on the pathogenesis and treatment of extranodal NK/T cell lymphomas (ENKTL).

Authors:  Bradley M Haverkos; Carrie Coleman; Alejandro A Gru; Zenggang Pan; Jonathan Brammer; Rosemary Rochford; Anjali Mishra; Christopher C Oakes; Robert A Baiocchi; Aharon G Freud; Pierluigi Porcu
Journal:  Discov Med       Date:  2017-03       Impact factor: 2.970

2.  Increased serum levels of interleukin-15 correlate with negative prognostic factors in extranodal NK/T cell lymphoma.

Authors:  Hua Wang; Jia-Yu Zhu; Cheng-Cheng Liu; Meng-Yuan Zhu; Jing-Hua Wang; Qi-Rong Geng; Yue Lu
Journal:  Med Oncol       Date:  2014-11-27       Impact factor: 3.064

3.  Elevated pretreatment serum levels of interferon-inducible protein-10 (CXCL10) predict disease relapse and prognosis in diffuse large B-cell lymphoma patients.

Authors:  Stephen M Ansell; Matthew J Maurer; Steven C Ziesmer; Susan L Slager; Thomas M Habermann; Brian K Link; Thomas E Witzig; William R Macon; Ahmet Dogan; James R Cerhan; Anne J Novak
Journal:  Am J Hematol       Date:  2012-06-03       Impact factor: 10.047

4.  The emerging role of CXCL10 in cancer (Review).

Authors:  Mingli Liu; Shanchun Guo; Jonathan K Stiles
Journal:  Oncol Lett       Date:  2011-05-09       Impact factor: 2.967

5.  CCL17 and CCL22/CCR4 signaling is a strong candidate for novel targeted therapy against nasal natural killer/T-cell lymphoma.

Authors:  Takumi Kumai; Toshihiro Nagato; Hiroya Kobayashi; Yuki Komabayashi; Seigo Ueda; Kan Kishibe; Takayuki Ohkuri; Miki Takahara; Esteban Celis; Yasuaki Harabuchi
Journal:  Cancer Immunol Immunother       Date:  2015-03-10       Impact factor: 6.968

6.  The JAK inhibitor AZD1480 regulates proliferation and immunity in Hodgkin lymphoma.

Authors:  E Derenzini; M Lemoine; D Buglio; H Katayama; Y Ji; R E Davis; S Sen; A Younes
Journal:  Blood Cancer J       Date:  2011-12-02       Impact factor: 11.037

7.  Involvement of IL-10 and TGF-β in HLA-E-mediated neuroblastoma migration and invasion.

Authors:  Zijun Zhen; Xiaofang Guo; Ru Liao; Kaibin Yang; Litong Ye; Zhiyao You
Journal:  Oncotarget       Date:  2016-07-12

8.  Predictive Value of Serum IFN-γ inducible Protein-10 and IFN-γ/IL-4 Ratio for Liver Fibrosis Progression in CHB Patients.

Authors:  Yadong Wang; Weiyan Yu; Chuan Shen; Wei Wang; Li Zhang; Fang Liu; Hui Sun; Yajuan Zhao; Honghao Che; Caiyan Zhao
Journal:  Sci Rep       Date:  2017-01-09       Impact factor: 4.379

9.  Prognostic significance of peripheral monocyte count in patients with extranodal natural killer/T-cell lymphoma.

Authors:  Jia-Jia Huang; Ya-Jun Li; Yi Xia; Yu Wang; Wen-Xiao Wei; Ying-Jie Zhu; Tong-Yu Lin; Hui-Qiang Huang; Wen-Qi Jiang; Zhi-Ming Li
Journal:  BMC Cancer       Date:  2013-05-03       Impact factor: 4.430

10.  Serum levels of interleukin-9 correlate with negative prognostic factors in extranodal NK/T-cell lymphoma.

Authors:  Jing Zhang; Wei-da Wang; Qi-Rong Geng; Liang Wang; Xiao-Qin Chen; Cheng-Cheng Liu; Yue Lv
Journal:  PLoS One       Date:  2014-04-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.